HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...
The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...
The Global Viral Vector Market was valued at approximately USD 3.10 billion in 2022 and is projected to grow at a robust CAGR of more than 11.5% during the forecast period 2023-2030. Read the Market ...
The vaccine is the only way to prevent measles, but it also prevents other illnesses. The other “M” stands for mumps, and the ...
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback